Endocrine-Related Cancer

Papers
(The TQCC of Endocrine-Related Cancer is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells91
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing67
Acknowledgement to reviewers55
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas54
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications49
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs44
Prognostic of recurrence and survival in poorly differentiated thyroid cancer44
Targeting growth hormone in cancer: future perspectives39
Celebrating the 80th anniversary of hormone ablation for prostate cancer36
Update on the genetics of paragangliomas36
Acknowledgement to reviewers36
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients35
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms34
Genistein induces endocrine resistance in human breast cancer by suppressing H3K27 trimethylation31
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells30
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts29
Metabolically active brown adipose tissue in PPGL: an observational cohort study28
Radioiodine treatment: an historical and future perspective28
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas27
Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet27
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells27
Gender-affirming care and endocrine-related cancers25
Whole-exome sequencing of rectal neuroendocrine tumors25
Therapy considerations in neuroendocrine prostate cancer: what next?24
Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer24
lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells23
Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma23
Antitumor immune response is associated with favorable survival in GEP-NEN G322
CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours22
Bone metastasis in endocrine-related cancer: unravelling invasion and destruction21
Distortion in transmission of pathogenic SDHB- and SDHD-mutated alleles from parent to offspring21
Immunotherapy for endocrine tumours: a clinician’s perspective20
Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis20
Effect of TSH levels during active surveillance of PTMC according to age20
RET signalling in the pituitary: a double-edged sword for differentiation, apoptosis and therapeutic strategies in acromegaly20
Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective19
Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer19
Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen19
Steroid profile in patients with breast cancer and in mice treated with mifepristone19
Exploring stem cell biology in pituitary tumors and derived organoids18
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms18
The role of the tumor microenvironment in papillary thyroid microcarcinoma nodal metastasis17
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors17
ThyroidPrint®: clinical utility for indeterminate thyroid cytology17
From bench to bedside in the sella: translational developments in pituitary tumour genetics16
Acknowledgement to reviewers16
Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study16
Acknowledgement to reviewers16
New therapeutic opportunities for women with low-grade serous ovarian cancer15
Inhibition of GATA2 in prostate cancer by a clinically available small molecule15
Efficacy of adavosertib therapy against anaplastic thyroid cancer14
Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review14
Exploring the tumor suppressor role of RIN1 in familial thyroid carcinoma14
Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000–2020: a population-based retrospective cohort study14
Mammary gland development and EDC-driven cancer susceptibility in mesenchymal ERα-knockout mice13
Ampullary composite gangliocytoma/neuroma and neuroendocrine tumor management13
AR gene rearrangement analysis in liquid biopsies reveals heterogeneity in lethal prostate cancer13
Genetic disorders and insulinoma/glucagonoma12
Diagnosis and management of parathyroid carcinoma: a state-of-the-art review12
Insights on epidemiology, morbidity and mortality of Cushing’s disease in Northern Ireland12
Cancer in Ecuadorian subjects with Laron syndrome (ELS)12
Reactivated thyroid hormone receptor β attenuates anaplastic thyroid cancer (ATC) stem cell activity12
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus12
In vivo and in vitro analysis of functional effects of the SDHD H50R variant12
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort11
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms11
Beyond the three P’s: adrenal involvement in MEN111
Non-pituitary GH regulation of the tissue microenvironment11
Spectrum and carcinogenic properties of thyroglobulin gene fusions in thyroid11
Deiodinases in thyroid tumorigenesis11
Cutoff value of thyroglobulin in needle aspirates for screening neck masses of thyroid carcinoma11
COL12A1 as a prognostic biomarker links immunotherapy response in breast cancer11
Mendelian randomization to investigate the link between TSH and thyroid cancer10
The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal10
Genetic variants and down-regulation of CACNA1H in pheochromocytoma10
In memoriam: Charis Eng MD PhD (1962–2024)10
Sexual dimorphism in thyroid cancer: evidence from preclinical studies10
miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L210
Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis10
International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes10
Genotype-specific development of MEN 2 constituent components in 683 RET carriers10
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma9
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms9
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center9
Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumors9
MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells9
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane9
Limited value of genetic profiling in guiding radioiodine therapy for metastatic differentiated thyroid cancer9
Mitochondrial dynamics and oxidative phosphorylation as critical targets in cancer9
Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover9
Unregulated LDL cholesterol uptake is detrimental to breast cancer cells9
Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic revie9
Surrogate molecular classification of LAR breast cancer in routine workflow9
Precocious puberty due to intracranial germ cell tumors: a case–control study9
Management of high-grade neuroendocrine neoplasms: impact of functional imaging9
Promoter mutation-independent TERT expression is related to the immune-enriched milieu in papillary thyroid cancer9
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading9
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs9
DNA methylation is a comprehensive marker for pediatric adrenocortical tumors9
The science behind the relations among cancer, height, growth patterns, and growth hormone axis9
MicroRNAs as regulators of tumor metabolism9
0.56795001029968